CEA is a protein expressed by some cancer cells. CEA may be measured as a tumour marker for these malignancies.
CEA is most commonly associated with colorectal carcinoma, although it may also be expressed by tumours elsewhere in the body, such as cancers of the breast, pancreas, lung, stomach and ovaries.
CEA should not be used as a screening test for the primary diagnosis of tumours.
If overnight - Frozen
CEA lacks sensitivity and specificity for any cancer and therefore it should not be used for screening or diagnostic purposes. However, CEA may be monitored in a patient with a known CEA-secreting tumour to assess for both response to treatment and recurrence or progression of known disease.
0 -5 ug/L
Paramagnetic particle, chemiluminescent immunoassay on the Beckman Coulter DxI 800
$26.56 (Exclusive of GST)
"*" indicates required fields